| Market Cap | ₹23,429Cr |
| ROE | 22.38% |
| P/E Ratio(TTM) | 43.41 |
| EPS(TTM) | 64.43 |
| P/B Ratio | 9.81 |
| Dividend Yield | 0.86% |
| Industry P/E | 59.02 |
| Book Value | 285.02 |
| Debt to Equity | 0.07 |
| Face Value | 10 |
| Parent Organisation | Dr Lal PathLabs Limited |
| Managing Director | Shankha Banerjee |
| Founded | 1949 |
| NSE Symbol | LALPATHLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Vijaya Diagnostic Centre | NA (0.00%) | 67.24 | ||
| Metropolis Healthcare | NA (0.00%) | 60.96 | ||
| Thyrocare Technologies | NA (0.00%) | 53.76 | ||
| Krsnaa Diagnostics | NA (0.00%) | 27.47 |